BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34512870)

  • 1. Construction of Potential Gene Expression and Regulation Networks in Prostate Cancer Using Bioinformatics Tools.
    Liu H; Li L; Fan Y; Lu Y; Zhu C; Xia W
    Oxid Med Cell Longev; 2021; 2021():8846951. PubMed ID: 34512870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.
    He JH; Han ZP; Zou MX; Wang L; Lv YB; Zhou JB; Cao MR; Li YG
    J Comput Biol; 2018 Feb; 25(2):146-157. PubMed ID: 28836827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Key MicroRNAs and the miRNA-mRNA Regulatory Pathways in Prostate Cancer by Bioinformatics Methods.
    Li D; Hao X; Song Y
    Biomed Res Int; 2018; 2018():6204128. PubMed ID: 30027097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential crucial genes and construction of microRNA-mRNA negative regulatory networks in osteosarcoma.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    Hereditas; 2018; 155():21. PubMed ID: 29760609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of competing endogenous RNA network to identify the key RNAs associated with prostate adenocarcinoma.
    Li Y; Yang Z
    Pathol Res Pract; 2018 Nov; 214(11):1811-1817. PubMed ID: 30195637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
    Chen B; Hua Z; Qin X; Li Z
    Neurochem Res; 2021 Feb; 46(2):197-212. PubMed ID: 33104965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.
    Khan MM; Mohsen MT; Malik MZ; Bagabir SA; Alkhanani MF; Haque S; Serajuddin M; Bharadwaj M
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.